Showing results (141-150 of 491) with videos related to

Sort By:
Pageof 50
Circulation|September 25, 2002
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groupsAndrzej Budaj, Salim Yusuf, Shamir R Mehta, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 10, 2005
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine, A Michael Lincoff, James J Ferguson, et al.
International Journal of Cardiology|November 5, 2013
An evaluation of composite indicators of hospital acute myocardial infarction care: a study of 136,392 patients from the Myocardial Ischaemia National Audit ProjectA D Simms, P D Batin, C F Weston, et al.
American Heart Journal|December 13, 2005
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) studyBasil S Lewis, Shamir R Mehta, Keith A A Fox, et al.
American Heart Journal|January 13, 2024
Identifying the highest risk vascular patients: Insights from the XATOA registrySonia S Anand, Victor Aboyans, Jackie Bosch, et al.
Thrombosis Journal|June 7, 2019
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)Jan Beyer-Westendorf, A John Camm, Keith A A Fox, et al.
Thrombosis and Haemostasis|September 6, 2003
Patterns of use of heparins in ACS. Correlates and hospital outcomes: the Global Registry of Acute Coronary Events (GRACE)Werner Klein, Wilfried Kraxner, Ronald Hödl, et al.
BMJ Open|February 25, 2014
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk scoreKeith A A Fox, Gordon Fitzgerald, Etienne Puymirat, et al.
American Heart Journal|February 25, 2020
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or bothKeith A A Fox, Sonia S Anand, Victor Aboyans, et al.
Circulation. Cardiovascular Quality and Outcomes|June 21, 2017
Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) RegistriesFrançois Schiele, Chris P Gale, Tabassome Simon, et al.
Pageof 50